T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Advanced Micro Devices
AMD
|
+$2.31B |
| 2 |
Apple
AAPL
|
+$1.58B |
| 3 |
Sherwin-Williams
SHW
|
+$1.37B |
| 4 |
HubSpot
HUBS
|
+$1.32B |
| 5 |
Kenvue
KVUE
|
+$1.25B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$4.37B |
| 2 |
Lam Research
LRCX
|
+$1.54B |
| 3 |
Applied Materials
AMAT
|
+$1.33B |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$1.19B |
| 5 |
Halliburton
HAL
|
+$1.16B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32.32% |
| 2 | Healthcare | 15.15% |
| 3 | Financials | 10.54% |
| 4 | Consumer Discretionary | 10.48% |
| 5 | Communication Services | 8.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2626
Cricut
CRCT
$1.24B
| $207K | ﹤0.01% |
29,784
+1,776
| +6% | +$10.7K |
|
2627
iShares National Muni Bond ETF
MUB
$45.9B
| – | – |
0
| – | – |
|
2628
Amerant Bancorp
AMTB
$1.14B
| $206K | ﹤0.01% |
9,610
+164
| +2% | +$3.6K |
|
|
BASE
2629
DELISTED
Couchbase
BASE
| $206K | ﹤0.01% |
12,731
-54,616
| -81% | -$945K |
|
2630
Hawthorn Bancshares
HWBK
$277M
| $206K | ﹤0.01% |
+8,222
| New | +$183K |
|
2631
Arhaus
ARHS
$1.37B
| $205K | ﹤0.01% |
16,596
-540,712
| -97% | -$7.3M |
|
2632
Accel Entertainment
ACEL
$1.01B
| $203K | ﹤0.01% |
17,397
-12,277
| -41% | -$135K |
|
2633
iShares S&P 500 Growth ETF
IVW
$77.9B
| $203K | ﹤0.01% |
+2,119
| New | +$196K |
|
2634
Pangaea Logistics
PANL
$496M
| $203K | ﹤0.01% |
27,998
| – | – |
|
2635
Fractyl Health
GUTS
$105M
| $203K | ﹤0.01% |
+79,813
| New | +$260K |
|
2636
Business First Bancshares
BFST
$1.05B
| $202K | ﹤0.01% |
+7,834
| New | +$186K |
|
2637
The Joint Corp
JYNT
$119M
| $202K | ﹤0.01% |
17,586
| – | – |
|
2638
Ranpak Holdings
PACK
$479M
| $202K | ﹤0.01% |
30,906
+355
| +1% | +$2.44K |
|
|
NAGE
2639
Niagen Bioscience
NAGE
$241M
| $202K | ﹤0.01% |
55,108
| – | – |
|
2640
Inseego
INSG
$77.7M
| $201K | ﹤0.01% |
12,270
| – | – |
|
2641
Rigel Pharmaceuticals
RIGL
$762M
| $201K | ﹤0.01% |
12,414
+1,110
| +10% | +$13.1K |
|
2642
TaskUs
TASK
$667M
| $201K | ﹤0.01% |
15,500
+3,000
| +24% | +$42.5K |
|
2643
Patria Investments
PAX
$1.88B
| $200K | ﹤0.01% |
17,860
-112,667
| -86% | -$1.34M |
|
2644
Virgin Galactic
SPCE
$475M
| $200K | ﹤0.01% |
32,659
+13,747
| +73% | +$91.9K |
|
|
TRML
2645
DELISTED
Tourmaline Bio
TRML
| $200K | ﹤0.01% |
+7,753
| New | +$129K |
|
|
SEG
2646
Seaport Entertainment Group
SEG
$366M
| $200K | ﹤0.01% |
+7,285
| New | +$207K |
|
|
SAVE
2647
DELISTED
Spirit Airlines, Inc.
SAVE
| $200K | ﹤0.01% |
83,068
+6,077
| +8% | +$16.7K |
|
2648
ClearPoint Neuro
CLPT
$470M
| $199K | ﹤0.01% |
17,700
| – | – |
|
|
MCW
2649
DELISTED
Mister Car Wash
MCW
| $198K | ﹤0.01% |
30,347
+521
| +2% | +$3.52K |
|
|
FIRY
2650
Firy Inc
FIRY
$158M
| $195K | ﹤0.01% |
34,592
| – | – |
|
Similar funds
T. Rowe Price Associates's Q3 2024 Portfolio in Review
As of Q3 2024, T. Rowe Price Associates held 3,059 positions worth $869B, up 3.9% from $836B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Trading was light in Q3 2024: portfolio turnover was 4.3%. T. Rowe Price Associates opened 82 new positions and exited 51, leaving the 3,059-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 32% of assets, down from 34% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q3 2024 buy was Lineage Inc: 4,699,854 shares worth $368M.
- T. Rowe Price Associates added most to Advanced Micro Devices in Q3 2024, an estimated $2.31B increase.
- T. Rowe Price Associates's biggest Q3 2024 reduction was NVIDIA, cutting an estimated $4.37B.
- T. Rowe Price Associates fully exited Morphic Holding, Inc. Common Stock in Q3 2024, selling an estimated $75.2M.
- T. Rowe Price Associates's ten largest holdings make up 34% of its $869B portfolio in Q3 2024.
- T. Rowe Price Associates opened 82 new positions and closed 51 in Q3 2024.
- T. Rowe Price Associates's portfolio value rose 3.9% quarter-over-quarter to $869B.
Based on T. Rowe Price Associates's 13F filing for Q3 2024, filed 14 Nov 2024.